Skip to search formSkip to main contentSkip to account menu

MacAB-TolC complex

Known as: MacAB-TolC complex location, macrolide transporter MacAB-TolC complex, macrolide transporter MacAB-TolC complex location 
The MacAB-TolC complex is a macrolide transporter complex found in E.coli and related gram-negative bacteria. Its transport activity is specific to… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Inaccurate and over prescription of antibacterial drugs has accelerated the development of antibiotic resistance amongst bacteria… 
2017
2017
Death is an inevitable fact of life. Throughout the centuries, humanity has sought to understand this sobering thought through… 
2016
2016
The resistance-nodulation-cell division family (RND) efflux pumps exemplify a unique phenomenon with drug resistance in different… 
2015
2015
Expelling heterologous compounds out of hosts by transporters is a potential strategy to enhance product titers in microbial cell… 
2012
2012
26 Control of membrane permeability is a key step in regulating the intracellular 27 concentration of antibiotics. Efflux pumps… 
2012
2012
....................................................................................................................................... 1 ACKNOWLEDGMENTS .................................................................................................................... 2 LIST OF FIGURES ............................................................................................................................ 8 LIST OF TABLES AND EQUATIONS.............................................................................................. 11 LIST OF ABRIEVIATAIONS ............................................................................................................ 12 CHAPTER 1 – INTRODUCTION ..................................................................................................... 14 1.1 Secretion systems...................................................................................................................... 14 1.1.1. Bacteria: adaptation and survival.................................................................................... 14 1.1.2. Secretion pathways in bacteria ....................................................................................... 14 1.1.3. Type I multidrug resistance (MDR) efflux systems ......................................................... 15 1.1.4. Antibiotic resistance and the resistance nodulation division (RND) family ..................... 17 1.1.5. The role of RND efflux systems in bacterial pathogenicity ............................................. 18 1.2. The AcrAB-TolC efflux system.................................................................................................. 18 1.2.1. The outer membrane protein TolC.................................................................................. 18 1.2.2. AcrAB-TolC RND efflux system ...................................................................................... 20 1.2.3. AcrAB-TolC assembly..................................................................................................... 20 1.2.4 The membrane fusion protein AcrA ................................................................................. 20 1.2.5. Substrate binding for export via TolC ............................................................................. 21 1.2.6. Substrates of the resistance nodulation division efflux system....................................... 23 1.3. Bacterial fatty acid and hydrocarbon production ....................................................................... 23 1.3.1. Microbial bio-fuels. .......................................................................................................... 23 1.3.2. Bacterial fatty acids......................................................................................................... 24 1.3.3 Fatty acid synthesis in bacteria........................................................................................ 25 1.3.4. Hydrocarbon biosynthesis .............................................................................................. 25 1.3.5. Advantages of utilising bacteria in bio-fuel production.................................................... 25 1.3.6. Hydrocarbon producing bacteria..................................................................................... 28 1.3.7. Vibrio furnissii ................................................................................................................. 29 1.4. The secretion of compounds for cell-cell signalling .................................................................. 30 1.4.1. Quorum derived signalling .............................................................................................. 30 1.4.2. The quorum regulatory Lux pathway in V. fischeri, V. harveyi and V. cholerae ............. 31 1.4.3. Bacterial signalling molecules: Homoserine lactones and autoinducers ........................ 34 
2010
2010
v Índice de Figuras ix Índice de Tabelas xi Lista de Abreviaturas xii 1. INTRODUÇÃO 1 1.1. Enterobacteriaceae 1 1.1.1… 
Review
2008
Review
2008
Objectives. The objectives of this thesis were to study mechanisms conferring cefuroxime resistance in clinical non-ESBL… 
2007
2007
Abstract Enterobacter cloacae is an emerging clinical pathogen that may be responsible for nosocomial infections. Management of…